Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Fusion transcripts are hybrid RNA molecules generated through genomic rearrangements or RNA-level fusion mechanisms. They represent important molecular features of many cancers and can function as oncogenic drivers, diagnostic biomarkers, prognostic indicators, and therapeutic targets. Since the discovery of the BCR::ABL1 fusion in chronic myeloid leukemia, numerous cancer-associated fusion transc...
Tertiary lymphoid structure (TLS) correlates with improved prognosis in melanoma. The role of solute carrier family 52 member A2 (SLC52A2) in mediating this interplay and influencing melanoma progression remains unclear. Integrated bioinformatics analysis of melanoma datasets (GSE3189, GSE19234, GSE46801, GSE4587, GSE238207, GSE53223) were applied to identify TLS-associated candidate genes. Machin...
OBJECTIVES: Oral submucous fibrosis (OSF) is a chronic and progressive potentially malignant disorder with an increased risk of transformation to oral...
OBJECTIVE: Breast ultrasound imaging is widely used for the early detection of malignant breast lesions. Although deep learning models have shown stro...
OBJECTIVE: To evaluate the performance and interpretability of multiple ML algorithms for survival prediction in prostate cancer (CaP) and to assess w...
Oral squamous cell carcinoma (OSCC) continues to be associated with a poor prognosis despite recent advances in surgical and adjuvant treatment. Altho...
Immunological biomarkers are increasingly relevant for personalized cancer treatment, but peripheral blood-derived biomarkers are not yet used to guid...
PURPOSE: To develop and externally validate a simplified apparent diffusion coefficient (ADC)-based MRI radiomics model for differentiating benign and...
To assess radiation burden and contrast medium load, image quality, and the performance of AI-reader and junior radiologists in evaluating coronary st...
Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) provides rich molecular imaging across the prostate ...
The increasing biological complexity and heterogeneity of cancer have driven a shift in oncology drug discovery from single-target approaches toward s...
Personalized neoantigen cancer vaccine is a promising strategy for precision immunotherapy by targeting patient-specific and mutation-derived tumor an...
MOTIVATION: As unique drugs positioned between small and macro molecules, anticancer peptides (ACPs) hold great potential in oncotherapy owing to thei...
Neuroblastoma (NB) is a common pediatric tumor that exhibits significant clinical heterogeneity and substantial prognostic variability. However, there...
Colorectal cancer (CRC) remains a leading cause of cancer mortality globally, with therapeutic efficacy hindered by tumor heterogeneity and drug resis...
Skin cancer is among the most common malignant tumors worldwide, and early detection is essential to improve patient survival and recovery. Convention...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment option for a significant proportion of patients with acute myel...
Lymphoma is a common cancer in dogs, which often presents as generalized peripheral lymphadenopathy. Fine needle aspiration is frequently used to inve...
Endocrine-disrupting chemicals (EDCs) are widely present in the environment and consumer products and may disturb thyroid hormone homeostasis. However...